Placebo - Staloral birch, oromucosal solution, STALORAL Birke 10 IR/ml und 300 IR/ml, Lösung zur Anwendung in der Mundhöhle, STALORAL Birke 300 IR/ml, Lösung zur Anwendung in der Mundhöhle
YOBI/SL79.22
Phase 3 small_molecule active
Quick answer
Placebo - Staloral birch, oromucosal solution, STALORAL Birke 10 IR/ml und 300 IR/ml, Lösung zur Anwendung in der Mundhöhle, STALORAL Birke 300 IR/ml, Lösung zur Anwendung in der Mundhöhle for Birch Pollen-induced Allergic Rhinoconjunctivitis is a Phase 3 program (small_molecule) at Allergen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allergen
- Indication
- Birch Pollen-induced Allergic Rhinoconjunctivitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active